BiomarkersTherapeuticTerm	Function	AssociatedCompoundsCCLE	AssociatedCompoundsCTDD	AssociatedCompoundsSanger	AssociatedColour
crizotinib	ALK inhibitor	PF2341066;crizotinib	crizotinib	NA	#2D9B1C
ceritinib	ALK inhibitor	NA	NA	NA	#2D9B1C
alectinib	ALK inhibitor	NA	NA	NA	#2D9B1C
sorafenib	Multi-target protein kinase inhibitor	Sorafenib 	sorafenib	Sorafenib	#FA6BEF
EGFR TKIs	EGFR TKI	Erlotinib;Lapatinib	cyanoquinoline.11;neratinib;tyrphostin.AG.1478;afatinib;canertinib;WZ8040;lapatinib;WZ4002;PD.153035;erlotinib	Erlotinib;Gefitnib;Lapatinib;BIBW2992	#D43608
dasatinib	Bcr-Abl TKI	NA	NA	Dasatinib	NA
erlotinib	EGFR TKI	Erlotinib	erlotinib	Erlotinib	#D43608
afatinib	EGFR/HER2 TKI	NA	afatinib	BIBW2992	#D43608
irreversible EGFR T790M inhibitors	irreversible EGFR T790M inhibitor	NA	NA	NA	NA
first-generation and irreversible EGFR TKIs	EGFR TKI	Erlotinib;Lapatinib	cyanoquinoline.11;neratinib;tyrphostin.AG.1478;erlotinib	Erlotinib;Gefitnib;Lapatinib;BIBW2992	#D43608
mTOR inhibitors	mTOR inhibitor	NA	PI.103;PIK.90;PP.30;sirolimus;BEZ235	JW.7.52.1;NVP.BEZ235;Rapamycin;Temsirolimus;AZD8055	#B2F0ED
PARP inhibitors	PARP inhibitor	NA	PJ.34;rucaparib;veliparib;X3.aminobenzamide;AG14361;NU.1025;olaparib	ABT.888;AG.014699;AZD.2281	#461234
FGFR inhibitors	FGFR inhibitor	TKI258	NA	PD.173074	#E9A468
PI3K pathway inhibitors	PI3K pathway inhibitor	NA	BEZ235;Compound.110;PI.103;PIK.75;PIK.90;TGX.115	TGX221;AZD6482;GDC0941;NVP.BEZ235	#C3FB13
cabozantinib	c-Met and VEGFR2 inhibitor	NA	cabozantinib	NA	NA
vandetanib	VEGFR and EGFR inhibitor	ZD.6474;vandetanib	vandetanib	NA	#783360
SRC inhibitors	SRC inhibitor	AZD0530;saracatinib	saracatinib	A.770041;AZD.0530;Bosutinib;Dastinib;WH.4.023	#F7436C
ALK inhibitors	ALK inhibitor	PF2341066;crizotinib;TAE684	LDN.193189;crizotinib;NVP.TAE684	NVP.TAE684;PF.02341066	#2D9B1C
dabrafenib	BRAF inhibitor	NA	dabrafenib	NA	#32AF81
cetuximab	EGFR inhibitor	NA	NA	NA	#D43608
HSP90 inhibitors	HSP90 inhibitor	X17.AAG	NVP.AUY922;SNX.2112;tanespimycin	X17.AAG;AUY922;CCT018159	#2C3A85
cisplatin	Interchalating agent	NA	NA	Cisplatin	NA
MEK inhibitors	MEK inhibitor	AZD6244;PD.0325901;selumetinib;PD0325901	selumetinib;PD318088;trametinib	PD.0325901;RDEA119;AZD6244;CI.1040	#445C0F
RET inhibitors	RET inhibitor	NA	regorafenib	AMG.706;CEP.701	#6B57D3
vemurafenib	BRAF inhibitor	NA	P.0850	NA	#32AF81
BET inhibitors	BET inhibitor	NA	JQ.1	NA	NA
IGF1R inhibitors	IGF1R inhibitor	AEW541;NVP-AEW541	BMS.536924;BMS.754807;linsitinib	BMS.536924;BMS.754807;GSK.1904529A;OSI.906	#8ECBFE
trametinib	MEK inhibitor	NA	NA	NA	#445C0F
CDK4 inhibitors	CDK4 inhibitor	PD.0332991;PD0332991	alvocidib;PHA.793887	CGP.082996;PD.0332991	#C47A0C
JAK/TBK1/IKK? inhibitor	JAK/TBK1/IKK? inhibitor	NA	TG.101348;BX.795	NA	NA
FAK inhibitors	FAK inhibitor	NA	NA	PF.562271	NA
nilotinib	TKI	Nilotinib	nilotinib	Nilotinib	#B3F7C0
ponatinib	TKI	NA	NA	NA	#B3F7C0
bosutinib	TKI	NA	NA	Bosutinib	#B3F7C0
AKT inhibitors	AKT inhibitor	NA	MK.2206;10.DEBC	MK.2206;A.443654	NA
everolimus	mTOR inhibitor	NA	NA	NA	#B2F0ED
BRAF inhibitors	BRAF inhibitor	PLX4720;RAF265	P.0850;dabrafenib;GDC.0879;PLX.4720;regorafenib;PLX.4032;RAF265	PLX4720;SB590885;AZ628	#32AF81
tankyrase inhibitors	tankyrase inhibitor	NA	XAV.939	NA	NA
enzalutamide	AR signaling inhibitor	NA	NA	NA	NA
ARN-509	AR inhibitor	NA	NA	NA	NA
flutamide	AR inhibitor	NA	flutamide	NA	NA
bicalutamide	AR inhibitor	NA	NA	Bicalutamide	NA
AR antagonists	AR antagonist	NA	flutamide;MDV.3100;pyrvinium.pamoate;BMS.641988	NA	NA
EZH2 inhibitor	EZH2 inhibitor	NA	NA	NA	NA
abiraterone	AR inhibitor	NA	NA	NA	NA
temozolomide	Alklylating agent	NA	NA	NA	NA
DNA-PKc inhibitors	DNA-PKc inhibitor	NA	KU.0060648;PI.103	NA	NA
AURK inhibitors	AURK inhibitor	NA	tozasertib	SL 0101.1;ZM.447439;BZ.795	NA
HDAC inhibitors	HDAC inhibitor	Panobinostat	tubastatin.A;vorinostat	Vorinostat;LAQ824;MS.275	#444B42
BCL2 inhibitors	BCL2 inhibitor	NA	ABT.737;gossypol;navitoclax;TW.37	ABT.263	NA
imatinib	TKI	NA	NA	Imatinib	#B3F7C0
ruxolitinib	JAK inhibitor	NA	NA	NA	NA
panitumumab	EGFR antibody	NA	NA	NA	NA
WEE1 inhibitors	WEE1 inhibitor	NA	MK.1775	681640	NA
platinum	Alkylating agent	NA	NA	NA	NA
ibrutinib	BTK inhibitor	NA	NA	NA	NA
CDK4/6 inhibitors	CDK4/6 inhibitor	PD.0332991;PD0332991	alvocidib	PD.0332991	#C47A0C
CDK2 inhibitors	CDK2 inhibitor	NA	BML.259;SNS.032;PHA.793887;dinaciclib;alvocidib	NA	#C47A0C
PDL1 inhibitors	PDL1 inhibitor	NA	NA	NA	NA
CDK2/4 inhibitors	CDK2/4 inhibitor	NA	BML.259	NA	#C47A0C	
letrozole	Aromatase inhibitor	NA	NA	NA	NA
daunorubicin	TOPII inhibitor	NA	idarubicin	NA	#C0C757
anti-EGFR mAbs	anti-EGFR mAbs	NA	NA	NA	NA
lapatinib	EGFR inhibitor	Lapatinib	lapatinib	Lapatinib	#D43608
gefitinib	EGFR inhibitor	NA	NA	Gefitinib	#D43608
sirolimus	mTOR inhibitor	NA	sirolimus	NA	#B2F0ED
EPHA3 inhibitors	EPHA3 inhibitor	NA	NA	NA	NA
neratinib	EGFR TKI	NA	neratinib	NA	#D43608
trastuzumab	HER2 antibody	NA	NA	NA	NA
pertuzumab	HER2 dimerization inhibitor	NA	NA	NA	NA
ado-trastuzumab emtansine	HER2 antibody	NA	NA	NA	NA
temsirolimus	mTOR inhibitor	NA	temsirolimus	Temsirolimus	#B2F0ED
anti-HER3 mAbs	anti-HER3 mAbs	NA	NA	NA	NA
anti-estrogens	anti-estrogen	NA	tamoxifen	NA	NA
steroids in early setting	steroids in early setting	NA	NA	NA	NA
anti-tubulin agents	anti-tubulin agent	Paclitaxel	ABT.751;CHM.1;CYT.997;paclitaxel	Paclitaxel;Vinblastine;Vinorelbine;Docetaxel;Epothilone B	#A198A0
dovitinib	FGFR3 inhibitor	NA	NA	NA	NA
pazopanib	TKI	NA	NA	Pazopanib	#B3F7C0
bortezomib	Proteosome inhibitor	NA	bortezomib	Bortezomib	NA
quizartinib	TKI	NA	NA	NA	#B3F7C0
aromatase inhibitors	aromatase inhhibitor	NA	NA	NA	NA
selumetinib	MEK inhibitor	AZD6244;selumetinib	selumetinib	AZD6244	#445C0F
IDH1 inhibitor	IDH1 inhibitor	NA	NA	NA	NA
IDH2 inhibitor	IDH2 inhibitor	NA	NA	NA	NA
VEGFR inhibitors	VEGFR inhibitor	Sorafenib	tivozanib;sorafenib	Sorafenib;AMG.706;Axitinib;Pazopanib	#BB64A0
sunitinib	RTK inhibitor	NA	NA	Sunitinib	NA
regorafenib	RTK inhibitor	NA	NA	NA	NA
gemcitabine	Nucleoside analogue	NA	gemcitabine	Gemcitabine	NA
liposomal doxorubicin	Anthracycline antibiotic	NA	NA	NA	NA
MDM2 inhibitors	MDM2 inhibitor	Nutlin.3	HLI.373;nutlin.3;RITA;serdemetan;SJ.172550	JNJ.26854165;Nutlin.3a	#914638
MDM2/MDMX inhibitors	MDM2/MDMX inhibitor	Nutlin.3	HLI.373;nutlin.3;RITA;serdemetan;SJ.172550	JNJ.26854165;Nutlin.3a	#914638	
rapamycin	mTOR inhibitor	NA	sirolimus	Rapamycin	#B2F0ED
PIM inhibitors	PIM inhibitor	NA	NA	SL 0101.1	NA
CDK7 inhibitors	CDK7 inhibitor	NA	NA	NA	NA
bevacizumab	VEGF-A antibody	NA	NA	NA	NA
Gamma secretase inhibitors	Gamma secretase inhibitor	L.685458	BMS.299897;L.685458	BMS.708163;Z.LLNIe.CHO	#BE378F
ERK inhibitors	ERK inhibitor	NA	Compound.11e;pluripotin	NA	XMD8.85	NA
pan-TRK inhibitor	pan-TRK inhibitor	Nilotinib;Sorafenib	sorefenib;nilotinib	Nilotinib;Sorafenib	NA
midostaurin	Multi-target protein kinase inhibitor	NA	NA	Midostaurin	#FA6BEF
Mytomycin C	Alkylating agent	NA	NA	Mitomycin C	NA
PDGFR inhibitors	PDGFR inhibitor	Sorafenib	sorafenib	Pazopanib;Sorafenib;Sunitinib;Imitinib;Dasatinib;Axitinib;AMG.706	NA
crenolanib	RTK inhibitor	NA	NA	NA	NA
aspirin in adjuvant setting	aspirin in adjuvant setting	NA	NA	NA	NA
ATRA	Retinoids	NA	ATRA	ATRA	NA
arsenic trioxide	Toxin	NA	NA	NA	NA
vismodegib	SMO inhibitor	NA	vismodegib	NA	NA
sirolimus	mTOR inhibitor	NA	sirolimus	Rapamycin	#B2F0ED
irinotecan plus CHK1/2 inhibitor in ATM deficient tumor	TOP inhibitor	Irinotecan;Topotecan	SN.38;topotecan	NA	#C0C757
spliceosome inhibitor	spliceosome inhibitor	NA	NA	NA	NA
SYK inhibitors	SYK inhibitor	NA	tamatinib	BAY 61.3606	#765729
anthracyclines	anthracycline	NA	idarubicin	NA	NA
carboplatin	Intercalating agent	NA	NA	NA	NA
pramlintide	Peptide hormone	NA	NA	NA	NA
BCR-ABL1 inhibitors	BCR-ABL1 inhibitor	NA	NA	GNF.2	NA
novel estrogen receptor degrader	novel estrogen receptor degrader	NA	NA	NA	NA
FLT3 inhibitors	FLT3 inhibitor	Sorafenib	sorafenib	Sorafenib;Sunitinib;VX.680;CEP.701	NA
PKC412	Multi-target protein kinase inhibitor	NA	NA	Midostaurin	#FA6BEF
BH3 mimetics	BH3 mimetic	NA	ABT.737	NA	NA
foretinib	c-Met and VEGFR-2 inhibitor	NA	NA	NA	NA
docetaxel	Microtubule dysregulation	NA	NA	Docetaxel	NA
axitinib	TKI	NA	NA	Axitinib	#B3F7C0
DOT1L inhibitors	DOT1L inhibitor	NA	NA	NA	NA
phenformin	Anit-growth	NA	NA	NA	NA
azacytidine	Nucleoside analogue	NA	NA	NA	NA
proteosome inhibitors	proteosome inhibitor	NA	BMS.299897;NA	Bortezomib;MG.132	#BE378F
lestaurtinib	TKI	NA	NA	NA	#B3F7C0
BCL-XL inhibitors	BCL-XL inhibitor	NA	ABT.737;navitoclax;TW.37	Obatoclax Mesylate;TW 37;ABT.263	NA
MET inhibitors	MET inhibitor	PHA.665752;PF2341066;crizotinib	PF.04217903;crizotinib	PF.02341066;PHA.665752	#D24A33